Table 5

Prognostic impact of reduced eGFR in women and men

	Crude OR for eGFR per 10-ml incline (95% CI)				Age-adjusted OR for eGFR per 10-ml incline (95% CI)				Multivariable adjusted OR for eGFR per 10-ml incline (95% CI)
	Women	p Value	Men	p Value	Women	p Value	Men	p Value	Women	p Value	Men	p Value
One-year mortality	0.46 (0.28 to 0.76)	<0.01	0.87 (0.59 to 1.30)	0.50	0.54 (0.31 to 0.93)	0.03	1.02 (0.65 to 1.60)	0.92	0.37 (0.15 to 0.89)	0.03	1.05 (0.63 to 1.76)	0.85
MACE	0.59 (0.40 to 0.85)	<0.01	0.92 (0.71 to 1.18)	0.49	0.64 (0.42 to 0.98)	0.04	1.00 (0.76 to 1.32)	0.99	0.61 (0.40 to 0.92)	0.02	1.05 (0.79 to 1.40)	0.73

Data presented as OR (95% CI) and p values if not otherwise indicated.
The primary model included 18 covariates. Backward elimination was used and covariates with p<0.05 were kept in the final model.
eGFR, estimated glomerular filtration rate; MACE, major adverse cardiac event.